← Eichor
Condition: Bipolar Disorder 1 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Bipolar Disorder 1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Right-sided 1-Hz Repetitive Transcranial Magnetic Stimulation (rTMS) Versus Left-sided Intermittent Theta Burst Stimulat
Phase 4 · 2 location(s) · Region Örebro County · NCT07026461
Feasibility and Preliminary Results of the Efficacy of Blue-Blocking Glasses on Manic Symptoms in Bipolar Disorder
NA · 1 location(s) · Centre Hospitalier St Anne · NCT07194278
Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
Phase N/A · 3 location(s) · Forschungsinstitut der Diabetes Akademie Mergentheim · NCT07212075
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed
Phase 1/Phase 2 · 1 location(s) · Alzamend Neuro, Inc. · NCT07540338
Evaluation of Efficiency of One Day Patient/Caregiver Psychoeducation on the Caregiver's Burden
NA · 1 location(s) · University Hospital, Montpellier · NCT05178966
Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness
NA · 1 location(s) · VA Office of Research and Development · NCT05157620
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Phase N/A · 6 location(s) · Beth Israel Deaconess Medical Center · NCT06740383
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
Phase 4 · 1 location(s) · Mayo Clinic · NCT07213466
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
NA · 3 location(s) · Stony Brook University · NCT06373016
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Phase 4 · 9 location(s) · Vanda Pharmaceuticals · NCT05648591
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Phase 2 · 22 location(s) · Rapport Therapeutics Inc. · NCT07046494
CLOZAPINE Response in Biotype-1
Phase 4 · 5 location(s) · University of Texas Southwestern Medical Center · NCT04580134
Melatonin and Response to Lithium
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05878730
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.